Learning Objectives
- Anticoagulation therapy has entered a new era with the introduction of the new oral anticoagulants (NOACs). NOACs afford a cost-effective opportunity to selectively turn on and turn off anticoagulation. Here, Dr John W Eikelboom reviews the general considerations in the reversal of oral anticoagulant therapy and the emerging evidence for the use of NOACs in stroke prevention and atrial fibrillation.
Faculty
John Eikelboom
MBBS, MSc, FRCPC
Associate Professor, Division of Hematology & Thromboembolism
Department of Medicine, McMaster University
Video Information
- Credit:No Credit Available
- Post Date:April 28, 2016
- Expiry Date:N/A
